HIV protease inhibitor report
By: written and prepared by Henry E. Chang and Jules Levin.
Contributors: Levin, Jules.; National AIDS Treatment Advocacy Project.; United States. Food and Drug Administration. Antiviral Drugs Advisory Committee. Meeting; NATAP Community Symposium on Protease Inhibitors: Current and Future Use (1996 : New York University Medical Center); Conference on Retroviruses and Opportunistic Infections (3rd : 1996 : Washington, D.C.)
Edition: 2nd ed.
Publisher: National AIDS Treatment Advocacy Project
Published: 1996
Place of publication: Brooklyn, NY (72 Orange St., #3C, Brooklyn 11201)
Language: eng
Number of pages: 37
Subjects: AIDS (Disease) -- Chemotherapy.; Protease inhibitors -- Therapeutic use.
Notes: Cover title.
"Second edition-3/96."
"Community lecture series on emerging issues on HIV/AIDS therapies."
"A compilation of the protease inhibitor data from the following meetings: NATAP Community Symposium on Protease Inhibitors: Current and Future Use, Farkas Auditorium, New York University Medical Center, January 6, 1996; the Third Conference on Retroviruses and Opportunistic Infections, Sheraton Washington, Washington, D.C., January 28-February 1, 1996; the FDA Antiviral Advisory Committee Meeting, Holiday Inn, Gaithersberg, Maryland, February 29 to March 1, 1996."